103 related articles for article (PubMed ID: 21414782)
1. Phenoxyacetic acids as PPARδ partial agonists: synthesis, optimization, and in vivo efficacy.
Evans KA; Shearer BG; Wisnoski DD; Shi D; Sparks SM; Sternbach DD; Winegar DA; Billin AN; Britt C; Way JM; Epperly AH; Leesnitzer LM; Merrihew RV; Xu RX; Lambert MH; Jin J
Bioorg Med Chem Lett; 2011 Apr; 21(8):2345-50. PubMed ID: 21414782
[TBL] [Abstract][Full Text] [Related]
2. Sulfonylthiadiazoles with an unusual binding mode as partial dual peroxisome proliferator-activated receptor (PPAR) γ/δ agonists with high potency and in vivo efficacy.
Keil S; Matter H; Schönafinger K; Glien M; Mathieu M; Marquette JP; Michot N; Haag-Diergarten S; Urmann M; Wendler W
ChemMedChem; 2011 Apr; 6(4):633-53. PubMed ID: 21400663
[TBL] [Abstract][Full Text] [Related]
3. Indanylacetic acid derivatives carrying 4-thiazolyl-phenoxy tail groups, a new class of potent PPAR alpha/gamma/delta pan agonists: synthesis, structure-activity relationship, and in vivo efficacy.
Rudolph J; Chen L; Majumdar D; Bullock WH; Burns M; Claus T; Dela Cruz FE; Daly M; Ehrgott FJ; Johnson JS; Livingston JN; Schoenleber RW; Shapiro J; Yang L; Tsutsumi M; Ma X
J Med Chem; 2007 Mar; 50(5):984-1000. PubMed ID: 17274610
[TBL] [Abstract][Full Text] [Related]
4. Identification of a PPARdelta agonist with partial agonistic activity on PPARgamma.
Connors RV; Wang Z; Harrison M; Zhang A; Wanska M; Hiscock S; Fox B; Dore M; Labelle M; Sudom A; Johnstone S; Liu J; Walker NP; Chai A; Siegler K; Li Y; Coward P
Bioorg Med Chem Lett; 2009 Jul; 19(13):3550-4. PubMed ID: 19464171
[TBL] [Abstract][Full Text] [Related]
5. Discovery of a novel class of PPARdelta partial agonists.
Shearer BG; Patel HS; Billin AN; Way JM; Winegar DA; Lambert MH; Xu RX; Leesnitzer LM; Merrihew RV; Huet S; Willson TM
Bioorg Med Chem Lett; 2008 Sep; 18(18):5018-22. PubMed ID: 18722772
[TBL] [Abstract][Full Text] [Related]
6. Identification and synthesis of a novel selective partial PPARdelta agonist with full efficacy on lipid metabolism in vitro and in vivo.
Sauerberg P; Olsen GS; Jeppesen L; Mogensen JP; Pettersson I; Jeppesen CB; Daugaard JR; Galsgaard ED; Ynddal L; Fleckner J; Panajotova V; Polivka Z; Pihera P; Havranek M; Wulff EM
J Med Chem; 2007 Apr; 50(7):1495-503. PubMed ID: 17343371
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and structure-activity relationships of a series of 3-aryl-4-isoxazolecarboxamides as a new class of TGR5 agonists.
Budzik BW; Evans KA; Wisnoski DD; Jin J; Rivero RA; Szewczyk GR; Jayawickreme C; Moncol DL; Yu H
Bioorg Med Chem Lett; 2010 Feb; 20(4):1363-7. PubMed ID: 20097073
[TBL] [Abstract][Full Text] [Related]
8. Discovery of para-alkylthiophenoxyacetic acids as a novel series of potent and selective PPARdelta agonists.
Zhang R; Wang A; DeAngelis A; Pelton P; Xu J; Zhu P; Zhou L; Demarest K; Murray WV; Kuo GH
Bioorg Med Chem Lett; 2007 Jul; 17(14):3855-9. PubMed ID: 17524639
[TBL] [Abstract][Full Text] [Related]
9. Improvement of water-solubility of biarylcarboxylic acid peroxisome proliferator-activated receptor (PPAR) δ-selective partial agonists by disruption of molecular planarity/symmetry.
Kasuga J; Ishikawa M; Yonehara M; Makishima M; Hashimoto Y; Miyachi H
Bioorg Med Chem; 2010 Oct; 18(20):7164-73. PubMed ID: 20843696
[TBL] [Abstract][Full Text] [Related]
10. Discovery and SAR of para-alkylthiophenoxyacetic acids as potent and selective PPARdelta agonists.
Zhang R; Deangelis A; Wang A; Sieber-McMaster E; Li X; Russell R; Pelton P; Xu J; Zhu P; Zhou L; Demarest K; Murray WV; Kuo GH
Bioorg Med Chem Lett; 2009 Feb; 19(4):1101-4. PubMed ID: 19168353
[TBL] [Abstract][Full Text] [Related]
11. Neuroprotective efficacy of the peroxisome proliferator-activated receptor delta-selective agonists in vitro and in vivo.
Iwashita A; Muramatsu Y; Yamazaki T; Muramoto M; Kita Y; Yamazaki S; Mihara K; Moriguchi A; Matsuoka N
J Pharmacol Exp Ther; 2007 Mar; 320(3):1087-96. PubMed ID: 17167170
[TBL] [Abstract][Full Text] [Related]
12. Design and synthesis of alpha-aryloxyphenylacetic acid derivatives: a novel class of PPARalpha/gamma dual agonists with potent antihyperglycemic and lipid modulating activity.
Shi GQ; Dropinski JF; McKeever BM; Xu S; Becker JW; Berger JP; MacNaul KL; Elbrecht A; Zhou G; Doebber TW; Wang P; Chao YS; Forrest M; Heck JV; Moller DE; Jones AB
J Med Chem; 2005 Jun; 48(13):4457-68. PubMed ID: 15974597
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and biological evaluation of N-alkylated 8-oxybenz[c]azepine derivatives as selective PPARδ agonists.
Luckhurst CA; Ratcliffe M; Stein L; Furber M; Botterell S; Laughton D; Tomlinson W; Weaver R; Chohan K; Walding A
Bioorg Med Chem Lett; 2011 Jan; 21(1):531-6. PubMed ID: 21075629
[TBL] [Abstract][Full Text] [Related]
14. 1,3,5-Trisubstituted aryls as highly selective PPARdelta agonists.
Epple R; Azimioara M; Russo R; Bursulaya B; Tian SS; Gerken A; Iskandar M
Bioorg Med Chem Lett; 2006 Jun; 16(11):2969-73. PubMed ID: 16546385
[TBL] [Abstract][Full Text] [Related]
15. Switching between agonists and antagonists at CRTh2 in a series of highly potent and selective biaryl phenoxyacetic acids.
Luker T; Bonnert R; Schmidt J; Sargent C; Paine SW; Thom S; Pairaudeau G; Patel A; Mohammed R; Akam E; Dougall I; Davis AM; Abbott P; Brough S; Millichip I; McInally T
Bioorg Med Chem Lett; 2011 Jun; 21(12):3616-21. PubMed ID: 21592791
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and identification of [1,2,4]thiadiazole derivatives as a new series of potent and orally active dual agonists of peroxisome proliferator-activated receptors alpha and delta.
Shen L; Zhang Y; Wang A; Sieber-McMaster E; Chen X; Pelton P; Xu JZ; Yang M; Zhu P; Zhou L; Reuman M; Hu Z; Russell R; Gibbs AC; Ross H; Demarest K; Murray WV; Kuo GH
J Med Chem; 2007 Aug; 50(16):3954-63. PubMed ID: 17608467
[TBL] [Abstract][Full Text] [Related]
17. Novel bisaryl substituted thiazoles and oxazoles as highly potent and selective peroxisome proliferator-activated receptor delta agonists.
Epple R; Cow C; Xie Y; Azimioara M; Russo R; Wang X; Wityak J; Karanewsky DS; Tuntland T; Nguyêñ-Trân VT; Cuc Ngo C; Huang D; Saez E; Spalding T; Gerken A; Iskandar M; Seidel HM; Tian SS
J Med Chem; 2010 Jan; 53(1):77-105. PubMed ID: 19928766
[TBL] [Abstract][Full Text] [Related]
18. [Design and synthesis of peroxisome proliferator-activated receptor (PPAR) delta agonists and its implication to the driving force to elicit PPAR delta selectivity].
Kasuga J; Oyama T; Nakagome I; Aoyama A; Sako K; Makishima M; Hirono S; Morikawa K; Hashimoto Y; Miyachi H
Yakugaku Zasshi; 2009 Jun; 129(6):709-18. PubMed ID: 19483413
[TBL] [Abstract][Full Text] [Related]
19. Discovery, design and synthesis of Y-shaped peroxisome proliferator-activated receptor δ agonists as potent anti-obesity agents in vivo.
Ham J; Hwang H; Kim E; Kim JA; Cho SJ; Ko J; Lee W; Lee J; Holla H; Banerjee J; Kim S; Yang I; Lee HJ; Shin K; Choi H; Nam SJ; Tak J; Hahn D; Oh T; Won DH; Lee TG; Choi J; Park MS; Seok C; Chin J; Kang H
Eur J Med Chem; 2012 Jul; 53():190-202. PubMed ID: 22534184
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and optimization of novel 4,4-disubstituted cyclohexylbenzamide derivatives as potent 11β-HSD1 inhibitors.
Sun D; Wang Z; Caille S; DeGraffenreid M; Gonzalez-Lopez de Turiso F; Hungate R; Jaen JC; Jiang B; Julian LD; Kelly R; McMinn DL; Kaizerman J; Rew Y; Sudom A; Tu H; Ursu S; Walker N; Willcockson M; Yan X; Ye Q; Powers JP
Bioorg Med Chem Lett; 2011 Jan; 21(1):405-10. PubMed ID: 21093258
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
